Viewing Study NCT05976893

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2025-12-25 @ 11:25 PM
Study NCT ID: NCT05976893
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-08-04
First Post: 2023-07-21
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer
Sponsor: Xiang Xie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ASCVD View
None Atherosclerotic Cardiovascular Disease View
None Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ASCVD View
None cancer View
None PCSK9 View